Ranza Elrayess

8PUBLICATIONS
25CO-AUTHORS
Biologically active moleculesMolecular targetsPredictive and prognostic markersBiomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 16, 2026
Ferulic and <i>p</i>-coumaric acid derivatives as dual EGFR-VEGFR2 inhibitors: design, semi-synthesis, and biological investigations.

|Dec 31, 2025
Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases.

Wagdy M Eldehna, Zainab M Elsayed, Mohamed R Elnagar

|Dec 24, 2025
Design and synthesis of sorafenib-inspired benzofuran hybrids as VEGFR-2 inhibitors: antiproliferative evaluation, mechanistic insights, and docking studies in hepatocellular carcinoma.

Mohamed S Shehda, Aya M Almatary, Mohamed S H Salem

|Oct 28, 2024
Development, biological evaluation, and molecular modelling of some benzene-sulfonamide derivatives as protein tyrosine phosphatase-1B inhibitors for managing diabetes mellitus and associated metabolic disorders.

Nagat Ghareb, Khaled M Darwish, Mohamed S Nafie

|Sep 30, 2024
Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation.

Asmaa S A Yassen, Sherief M Abdel-Wahab, Khaled M Darwish

|Mar 31, 2023
2-Phenylquinazolin-4(3H)-one scaffold as newly designed, synthesized VEGFR-2 allosteric inhibitors with potent cytotoxicity through apoptosis.

Ranza Elrayess, Mohamed S Elgawish, Mohamed S Nafie

Pageof 2

Frequent Collaborators

5 joint publications

Mohamed S Nafie

4 joint publications

Asmaa S A Yassen

3 joint publications

Khaled M Darwish

2 joint publications

Sameh S Elhady